000 | 01929 a2200517 4500 | ||
---|---|---|---|
005 | 20250513193519.0 | ||
264 | 0 | _c19991118 | |
008 | 199911s 0 0 eng d | ||
022 | _a0196-4763 | ||
024 | 7 |
_a10.1002/(sici)1097-0320(19991015)38:5<238::aid-cyto6>3.0.co;2-o _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLamb, L S | |
245 | 0 | 0 |
_aExpression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease. _h[electronic resource] |
260 |
_bCytometry _cOct 1999 |
||
300 |
_a238-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBiomarkers _xanalysis |
650 | 0 | 4 | _aBone Marrow Transplantation |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 | _aCell Separation |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aGraft vs Host Disease _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 |
_aLymphocyte Depletion _xmethods |
650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
650 | 0 | 4 |
_aReceptors, Immunologic _xbiosynthesis |
650 | 0 | 4 | _aReceptors, OX40 |
650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
650 | 0 | 4 | _aTransplantation Conditioning |
650 | 0 | 4 |
_aTumor Necrosis Factor Receptor Superfamily, Member 7 _xbiosynthesis |
700 | 1 | _aAbhyankar, S A | |
700 | 1 | _aHazlett, L | |
700 | 1 | _aO'Neal, W | |
700 | 1 | _aFolk, R S | |
700 | 1 | _aVogt, S | |
700 | 1 | _aParrish, R S | |
700 | 1 | _aBridges, K | |
700 | 1 | _aHenslee-Downey, P J | |
700 | 1 | _aGee, A P | |
773 | 0 |
_tCytometry _gvol. 38 _gno. 5 _gp. 238-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0320(19991015)38:5<238::aid-cyto6>3.0.co;2-o _zAvailable from publisher's website |
999 |
_c10473657 _d10473657 |